nprnews_____ = ||| lubuntu at wor2|||Citing Safety Concerns, WHO Halts Hydroxychloroquine Trial||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||The WHO cited a scientific study published last week suggesting that proposed COVID-19 drug hydroxychloroqine may do more harm than good in halting its study to review data.

A pharmacy tech pours out pills of hydroxychloroquine May 20 at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. After a study found COVID-19 patients using the drug were dying at higher rates, the World Health Organization announced it would suspend its clinical trial.

George Frey/AFP via Getty Images

hide caption

toggle caption

George Frey/AFP via Getty Images

Coronavirus Live Updates

Citing Safety Concerns, WHO Halts Hydroxychloroquine Trial

The WHO cited a scientific study published last week suggesting that proposed COVID-19 drug hydroxychloroqine may do more harm than good in halting its study to review data.

Loading…